A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries
Clinical trial NCT06887959 · COMPLETED
Trial details
- NCT number
- NCT06887959
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-27
- Primary completion
- 2025-10-27
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.